New Study Investigates the Impact of ORi-Guided Oxygen Titration on Hyperoxemia-Mediated Morbidity During One-Lung Ventilation
Go back to New Study Investigates the Impact of ORi-Guided Oxygen Titration on Hyperoxemia-Mediated Morbidity During One-Lung Ventilation| Masimo Corporation (NASDAQ: MASI) | Delayed: 134.77 -1.15 (0.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $135.92 | 52 Week High | $62.00 | |||
| Open | $136.35 | 52 Week Low | $33.03 | |||
| Day High | $137.44 | P/E | 132.13 | |||
| Day Low | $133.64 | EPS | $1.02 | |||
| Volume | 341,165 | |||||
